HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selexipag in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome: First Report.

AuthorsKarim El-Kersh, Sally Suliman, J Shaun Smith
JournalAmerican journal of therapeutics (Am J Ther) 2018 Nov/Dec Vol. 25 Issue 6 Pg. e714-e715 ISSN: 1536-3686 [Electronic] United States
PMID29521655 (Publication Type: Case Reports, Letter)
Chemical References
  • Acetamides
  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Phosphodiesterase 5 Inhibitors
  • Pyrazines
  • selexipag
Topics
  • Acetamides (therapeutic use)
  • Adult
  • Aged
  • Antihypertensive Agents (therapeutic use)
  • Cardiac Catheterization
  • Drug Therapy, Combination
  • Eisenmenger Complex (complications)
  • Endothelin Receptor Antagonists (therapeutic use)
  • Female
  • Humans
  • Hypertension, Pulmonary (diagnosis, drug therapy, etiology)
  • Middle Aged
  • Phosphodiesterase 5 Inhibitors (therapeutic use)
  • Pyrazines (therapeutic use)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: